Literature DB >> 18622581

Malignant prolactinoma with craniospinal metastasis in a 12-year-old boy.

Abel Po-Hao Huang1, Shih-Hung Yang, Chi-Cheng Yang, Meng-Fai Kuo, Mu Zon Wu, Yong-Kwang Tu.   

Abstract

The authors report the clinical features of and imaging studies on a rare case of pediatric malignant prolactinoma. A 12-year-old boy presented with ataxia, blurred vision, and consciousness disturbance. He had received transcranial surgery and adjuvant radiotherapy. However, the tumor regrew with craniospinal metastasis 16 months after the operation. The relevant literature was reviewed regarding the clinical presentation, pathogenesis, treatment approaches, and prognosis of malignant prolactinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18622581     DOI: 10.1007/s11060-008-9626-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report.

Authors:  I E McCutcheon; D R Pieper; G N Fuller; R S Benjamin; K E Friend; R F Gagel
Journal:  Neurosurgery       Date:  2000-05       Impact factor: 4.654

3.  Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

Authors:  Camilo E Fadul; Andrew L Kominsky; Louise P Meyer; Linda S Kingman; William B Kinlaw; C Harker Rhodes; Clifford J Eskey; Nathan E Simmons
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

4.  Cushing's disease due to pituitary carcinoma.

Authors:  M S Zafar; R C Mellinger; J L Chason
Journal:  Henry Ford Hosp Med J       Date:  1984

Review 5.  Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.

Authors:  M Sironi; G Cenacchi; L Cozzi; G Tonnarelli; M Iacobellis; D Treré; A Assi
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

6.  Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma.

Authors:  A Zahedi; G L Booth; H S Smyth; W E Farrell; R N Clayton; S L Asa; S Ezzat
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

7.  Pituitary carcinoma: a clinicopathologic study of 15 cases.

Authors:  P J Pernicone; B W Scheithauer; T J Sebo; K T Kovacs; E Horvath; W F Young; R V Lloyd; D H Davis; B L Guthrie; W C Schoene
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

Review 8.  Clinical review: Diagnosis and management of pituitary carcinomas.

Authors:  Gregory A Kaltsas; Panagiotis Nomikos; George Kontogeorgos; Michael Buchfelder; Ashley B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

Review 9.  Pituitary carcinoma: a review of the literature.

Authors:  Brian T Ragel; William T Couldwell
Journal:  Neurosurg Focus       Date:  2004-04-15       Impact factor: 4.047

10.  Thyrotropin-secreting pituitary carcinoma.

Authors:  A J Mixson; T C Friedman; D A Katz; I M Feuerstein; J K Taubenberger; J M Colandrea; J L Doppman; E H Oldfield; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.